Administering the respiratory syncytial virus (RSV) prefusion F protein vaccine (Arexvy) at the same time as the adjuvanted seasonal quadrivalent influenza vaccine stimulated an adequate immune ...
(HealthDay News) — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results